Prenatal stress, glucocorticoids and the programming of adult disease

Elizabeth C. Cottrell

Frontiers in Behavioral Neuroscience · 2009 · 629 citations · 75 references

DOIFull text

Open access

Concepts

TL;DR

Prenatal stress and excess glucocorticoids are linked to later cardio‑metabolic, neuroendocrine, and psychiatric disorders, partly through reduced placental 11β‑HSD2 activity that lowers birth weight and increases blood pressure. Epigenetic changes in chromatin that alter tissue‑specific glucocorticoid receptor expression are thought to mediate the programming effects of early life stress and glucocorticoids. Early excess glucocorticoids can permanently alter glucocorticoid signalling, providing short‑term adaptive benefits but raising the risk of later disease.

Abstract

Numerous clinical studies associate an adverse prenatal environment with the development of cardio-metabolic disorders and neuroendocrine dysfunction, as well as an increased risk of psychiatric diseases in later life. Experimentally, prenatal exposure to stress or excess glucocorticoids in a variety of animal models can malprogram offspring physiology, resulting in a reduction in birth weight and subsequently increasing the likelihood of disorders of cardiovascular function, glucose homeostasis, hypothalamic-pituitary-adrenal (HPA) axis activity and anxiety-related behaviours in adulthood. During fetal development, placental 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) provides a barrier to maternal glucocorticoids. Reduced placental 11β-HSD2 in human pregnancy correlates with lower birth weight and higher blood pressure in later life. Similarly, in animal models, inhibition or knockout of placental 11β-HSD2 lowers offspring birth weight, in part by reducing glucose delivery to the developing fetus in late gestation. Molecular mechanisms thought to underlie the programming effects of early life stress and glucocorticoids include epigenetic changes in target chromatin, notably affecting tissue-specific expression of the intracellular glucocorticoid receptor (GR). As such, excess glucocorticoids in early life can permanently alter tissue glucocorticoid signalling, effects which may have short-term adaptive benefits but increase the risk of later disease.

References

75